Home
[an error occurred while processing this directive]
Quality survey Health benefits Safety Reading labels Ask the supplier Standards & regulations



Editorials





Testing news
Search
Links
Glossary
Glossary
Ask the expert
Bookstore
Sponsorship
Contact us
Disclaimer
Privacy policy
Sponsorship
 

Research news

Pharmaceutical Scientists Present Groundbreaking Research Including Two Herbal Treatments For Lung and Skin Cancer
Arlington VA, 31 October 2003

New developments in biological warfare protection, roundtable discussions with the FDA and advances in therapies dealing with skin cancer, alcoholism and Alzheimer's disease headline this year's Annual Meeting and Exposition of the American Association of Pharmaceutical Scientists (AAPS).

The gathering of 7,500 pharmaceutical scientists was held October 26-30 in Salt Lake City, Utah at the Salt Palace Convention Center. New findings from academia, industry, government and other research institutions worldwide, include two nutraceuticals:

Nutraceuticals Show Astounding Results for the Treatment of Cancer—A scientist from China and assistant professor at St. John's University in New York, combined his knowledge of ancient traditional Chinese medicine with Western research methods. In his quest to battle lung cancer, the leading cause of cancer deaths in both men and women, Dr. Shao studied the effects of the Chinese herb oldenlandia diffusa. He and his team discovered that two weeks of daily oral administration of an extract of oldenlandia diffusa reduced lung cancer colonies by 70 percent!

Another nutraceutical research finding focuses on the treatment and prevention of skin cancer, the most common form of cancer in the United States. A South Dakota State University research team has discovered that topically applying pomegranate seed oil prevents skin cancer and limits its growth.

Other findings outside the realm of dietary supplements included new approaches to treating alcoholism, a sponge for combating chemical warfare agents, a remote-controlled ingestible capsule that can deliver drugs or take measurements or pictures within a patient's body, and a new intranasal drug-delivery method that bypasses the blood-brain barrier and may prove useful for combating brain disorders like Alzheimer's and Parkinson's diseases.

About AAPS PharmSci™

All abstracts presented at the AAPS Annual Meeting are published in a supplement to AAPS PharmSci™ (www.aapspharmsci.org), the organization's peer-reviewed, online journal. AAPS PharmSci™ offers a forum for the rapid exchange and dissemination of scientific knowledge in the pharmaceutical sciences.

About AAPS

AAPS is a professional scientific society of more than 11,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS aims to advance science through the open exchange of scientific knowledge, serve as an information resource and contribute to human health through pharmaceutical research and development.

Source

American Association of Pharmaceutical Scientists (www.aapspharmaceutica.com).end-of-story

 

   
[an error occurred while processing this directive]
Health benefits Safety Reading labels Ask the supplier Standards & regulations Contact us

(c) Copyright 1999-2003 Dietary Supplement Quality Initiative. For permission to reprint, please contact our editor.